Capital Fund Management (CFM)
EW icon

Capital Fund Management (CFM)’s Edwards Lifesciences EW Stock Holding History

Capital Fund Management (CFM)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,061
Closed -$1.32M – 2214
2025
Q4 		$1.37M Buy
+16,061
New +$1.32M ﹤0.01% 1883
2025
Q2 		– Sell
-174,297
Closed -$13M – 2386
2025
Q1 		$12.6M Sell
174,297
-187,394
-52% -$13.4M 0.04% 598
2024
Q4 		$26.8M Sell
361,691
-157,612
-30% -$11M 0.07% 385
2024
Q3 		$34.3M Buy
519,303
+483,647
+1,356% +$35.1M 0.09% 286
2024
Q2 		$3.29M Buy
+35,656
New +$3.16M 0.01% 1159
2023
Q4 		– Sell
-369,493
Closed -$25.7M – 2156
2023
Q3 		$25.6M Sell
369,493
-32,891
-8% -$2.64M 0.09% 300
2023
Q2 		$38M Sell
402,384
-39,453
-9% -$3.43M 0.15% 174
2023
Q1 		$36.6M Buy
441,837
+174,136
+65% +$13.7M 0.17% 141
2022
Q4 		$20M Buy
267,701
+225,879
+540% +$17.4M 0.13% 195
2022
Q3 		$3.46M Sell
41,822
-137,106
-77% -$13.2M 0.03% 675
2022
Q2 		$17M Buy
178,928
+159,065
+801% +$16.5M 0.15% 169
2022
Q1 		$2.34M Sell
19,863
-100,126
-83% -$11.2M 0.02% 892
2021
Q4 		$15.5M Buy
119,989
+95,744
+395% +$11.2M 0.11% 257
2021
Q3 		$2.74M Sell
24,245
-82,361
-77% -$9.4M 0.02% 797
2021
Q2 		$11M Sell
106,606
-262,903
-71% -$24.8M 0.09% 309
2021
Q1 		$30.9M Buy
369,509
+54,328
+17% +$4.59M 0.34% 64
2020
Q4 		$28.8M Buy
315,181
+192,730
+157% +$16M 0.27% 87
2020
Q3 		$9.77M Sell
122,451
-264,320
-68% -$20.6M 0.12% 205
2020
Q2 		$26.7M Sell
386,771
-86,773
-18% -$6.17M 0.42% 54
2020
Q1 		$29.8M Buy
473,544
+97,866
+26% +$7.06M 0.46% 32
2019
Q4 		$29.2M Buy
375,678
+326,409
+663% +$25.5M 0.23% 103
2019
Q3 		$3.61M Buy
+49,269
New +$3.46M 0.03% 593
2018
Q1 		– Sell
-78,012
Closed -$3.39M – 1922
2017
Q4 		$2.93M Buy
+78,012
New +$2.86M 0.02% 847
2017
Q3 		– Sell
-411,240
Closed -$15.7M – 1590
2017
Q2 		$16.2M Sell
411,240
-794,805
-66% -$29M 0.13% 210
2017
Q1 		$37.8M Buy
1,206,045
+1,010,709
+517% +$31.6M 0.32% 77
2016
Q4 		$6.1M Buy
+195,336
New +$6.33M 0.05% 428
2016
Q3 		– Sell
-1,419,036
Closed -$53.4M – 1629
2016
Q2 		$47.2M Buy
1,419,036
+1,405,704
+10,544% +$48.1M 0.44% 50
2016
Q1 		$392K Sell
13,332
-1,849,665
-99% -$51M ﹤0.01% 1238
2015
Q4 		$49M Buy
1,862,997
+946,659
+103% +$24.6M 0.5% 31
2015
Q3 		$21.7M Buy
916,338
+527,868
+136% +$12.7M 0.24% 100
2015
Q2 		$9.22M Buy
388,470
+132,342
+52% +$2.99M 0.12% 229
2015
Q1 		$6.08M Buy
+256,128
New +$5.75M 0.08% 293
2014
Q4 		– Sell
-37,584
Closed -$755K – 1648
2014
Q3 		$640K Buy
+37,584
New +$593K 0.01% 1077
2014
Q2 		– Sell
-28,800
Closed -$356K – 1741
2014
Q1 		$356K Buy
+28,800
New +$332K ﹤0.01% 1385

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Fund Management (CFM)'s EW Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 16,061 shares — an estimated $1.32M sold.

Capital Fund Management (CFM) first reported a position in EW in Q1 2014 and held it in 34 quarters. The position peaked at $49M in Q4 2015. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 16,061 Edwards Lifesciences shares in Q1 2026, an estimated $1.32M.
  • Capital Fund Management (CFM) first reported a position in Edwards Lifesciences in Q1 2014 and held it in 34 quarters.
  • Capital Fund Management (CFM)'s Edwards Lifesciences position peaked at $49M in Q4 2015.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.